» Articles » PMID: 27707245

RENEB - Running the European Network of Biological Dosimetry and Physical Retrospective Dosimetry

Abstract

Purpose: A European network was initiated in 2012 by 23 partners from 16 European countries with the aim to significantly increase individualized dose reconstruction in case of large-scale radiological emergency scenarios.

Results: The network was built on three complementary pillars: (1) an operational basis with seven biological and physical dosimetric assays in ready-to-use mode, (2) a basis for education, training and quality assurance, and (3) a basis for further network development regarding new techniques and members. Techniques for individual dose estimation based on biological samples and/or inert personalized devices as mobile phones or smart phones were optimized to support rapid categorization of many potential victims according to the received dose to the blood or personal devices. Communication and cross-border collaboration were also standardized. To assure long-term sustainability of the network, cooperation with national and international emergency preparedness organizations was initiated and links to radiation protection and research platforms have been developed. A legal framework, based on a Memorandum of Understanding, was established and signed by 27 organizations by the end of 2015.

Conclusions: RENEB is a European Network of biological and physical-retrospective dosimetry, with the capacity and capability to perform large-scale rapid individualized dose estimation. Specialized to handle large numbers of samples, RENEB is able to contribute to radiological emergency preparedness and wider large-scale research projects.

Citing Articles

RENEB interlaboratory comparison for biological dosimetry based on dicentric chromosome analysis and cobalt-60 exposures higher than 2.5 Gy.

Bucher M, Endesfelder D, Pojtinger S, Baeyens A, Barquinero J, Beinke C Sci Rep. 2025; 15(1):5485.

PMID: 39952996 PMC: 11828874. DOI: 10.1038/s41598-025-89966-2.


Retrospective OSL Dosimetry With Common Pharmaceuticals and Food Supplements.

Ekendahl D, Reimitz D Front Public Health. 2022; 10:908016.

PMID: 35784234 PMC: 9243327. DOI: 10.3389/fpubh.2022.908016.


Differences in the Awareness and Knowledge of Radiological and Nuclear Events Among Medical Workers in Japan.

Ochiai K, Oka T, Kato N, Kondo Y, Otomo Y, Swienton R Front Public Health. 2022; 10:808148.

PMID: 35433584 PMC: 9006773. DOI: 10.3389/fpubh.2022.808148.


Public health response and medical management of internal contamination in past radiological or nuclear incidents: A narrative review.

Li C, Alves Dos Reis A, Ansari A, Bertelli L, Carr Z, Dainiak N Environ Int. 2022; 163:107222.

PMID: 35378442 PMC: 9749825. DOI: 10.1016/j.envint.2022.107222.


A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient Radiosensitivity.

Howe O, White L, Cullen D, OBrien G, Shields L, Bryant J Int J Mol Sci. 2021; 22(19).

PMID: 34638945 PMC: 8508881. DOI: 10.3390/ijms221910607.